Brief: China Biotech Services Expects FY Net Loss Of Not More Than HK$100 Million
06/03/2026 17:31
March 6 (Reuters) - China Biotech Services Holdings Ltd 8037.HK: EXPECTS FY2025 NET LOSS OF NOT MORE THAN HK$100 MILLION EXPECTED RESULT DUE TO RECEIPT OF HK$14 MILLION INSURANCE COMPENSATION IN FY FOR HAINAN SITE DAMAGES, OTHERS Further company coverage: 8037.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)